Clin2
NCT07127146Worth exploringNot yet recruiting

Brain imaging study of pain in Parkinson's disease

Parkinson Disease

Part of Brain & nervous system, Pain clinical trials.

This study uses brain scans (MRI and PET) to understand how brain chemicals relate to pain in Parkinson's disease. It may help find better ways to treat pain in the future.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
55 people
Ages
30 years to 75 years
Study type
Interventional

Who can take part

  • You have a confirmed diagnosis of Parkinson's disease
  • Your Parkinson's medication has been at the same dose for at least 4 weeks
  • You have either: chronic pain lasting more than 3 months (with pain level at least 4 out of 10), or you have no chronic pain (with pain below 3 out of 10)
  • You must be able to have an MRI and PET scan (no pacemaker, metal implants, or severe claustrophobia)
  • You must be able to temporarily stop certain pain medications (like opioids) for one week before the imaging tests

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06008704Recruiting
PET scan study of pain in Parkinson's disease

This study uses a special brain scan (PET) to look at the serotonin system in people with Parkinson's who have chronic pain. The goal is to understand why some people feel pain and how the brain chemical serotonin might be involved.

Toulouse, Haute-Garonne
NCT06084533Enrolling by invitation
Brain inflammation imaging in Parkinson's disease

This study uses a special PET scan to look for signs of brain inflammation in people with Parkinson's disease. It aims to understand how inflammation relates to Parkinson's and may help in developing new treatments.

St Louis, Missouri
NCT05981261Recruiting
Experimental pain study in Parkinson's and healthy adults

This study looks at how people with Parkinson’s, treated either with levodopa or deep brain stimulation (DBS), and healthy volunteers experience pain. The goal is to understand how Parkinson’s treatments affect pain perception.

Aarhus
NCT06289582Recruiting· Early Phase 1
Brain imaging study for Parkinson's disease

This study uses a special PET scan to look at inflammation in the brain of people with Parkinson's disease or those at risk for it. The goal is to better understand the disease and possibly find new ways to track its progression.

Birmingham, Alabama
NCT06875765Recruiting
Long-term brain imaging study for Parkinson's patients

This study uses brain scans to look at nerve endings in people with Parkinson's disease over time. It may help researchers understand how the disease progresses.

Leuven
NCT07640555Recruiting· Early Phase 1
Brain imaging study for Parkinson's and related movement disorders

This research study tests a new type of brain scan (called a PET scan) that may help detect early signs of Parkinson's disease and similar conditions. You'll receive the scan and may have a spinal tap to check for specific protein markers.

New Haven, Connecticut

Hear when a new Parkinson Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.